Search results
Lexaria begins study on enhanced drug delivery technology By Investing.com
Investing.com· 18 minutes agoLexaria Bioscience Corp. (NASDAQ:LEXX), a leader in drug delivery platforms, has initiated a 12-week...
New menopause drugs treat hot flashes, but women may face insurance hurdles
NBC NEWS· 17 hours agoNew drugs to treat debilitating menopause symptoms — namely hot flashes — are finally on the market...
FDA grants breakthrough therapy status for Nuvalent’s NVL-655
Pharmaceutical Technology via Yahoo Finance· 7 hours agoThe US Food and Drug Administration (FDA) has granted breakthrough therapy designation (BTD) for...
Researcher discovers drug that may delay onset of Alzheimer's, Parkinson's disease and treat...
Medical Xpress· 2 hours agoMuch like the body, the brain has its own lymphatic system that clears away cellular waste. "It's a lot like a sewer system—and that means it has to drain well for it to work ...
Here’s what to know about innovative treatment Dr. Richard Scolyer used on his own deadly cancer: ‘A...
NY Post via Yahoo News· 22 hours ago“I would say it is all consistent with a lot of developments in immunotherapy, suggesting that...
Biogen and Ionis halt ALS drug development after trial setback By Investing.com
Investing.com· 1 day agoBiogen Inc. (NASDAQ:BIIB) and Ionis Pharmaceuticals, Inc. (NASDAQ:IONS) have announced the...
PsychedelicNewsWire Named Official Media Sponsor of the 4th Annual Psychedelic Therapeutics and Drug...
Benzinga· 4 hours agoLOS ANGELES, May 17, 2024 (GLOBE NEWSWIRE) -- PsychedelicNewsWire ("PNW"), a specialized communications platform for the psychedelics sector and one of the 60+ brands powered by IBN ("InvestorBrandNetwork"), is pleased
KRAS inhibitors: The next frontier beckons
Pharmaceutical Technology via Yahoo Finance· 1 day ago“About 40% of lung cancer patients have brain metastasis. That's a big number,” says Azmi. “Now, if you have a drug that can cross the blood-brain ...
EDI Collaboration Builds Off Feltri’s MS Drug Research
UB Reporter· 1 day agoFast Forward provides research funding to commercial entities who develop promising new therapies for the treatment of MS, a demyelinating disease of the central nervous system impacting the ...
High-Potency Cannabis Tied to Impaired Brain Development
Medscape· 5 days agoIt's becoming clear that adolescent brain is particularly vulnerable to cannabis, especially today's...
